Lastly, we will utilize animal models to further evaluate the potential role of SMAD3/ITGA6 in chemosensitivity of NSCLC, providing new theoretical evidence for the optimization of therapeutic strategies for NSCLC. This evidence concerns the gene SMAD3 and non-small cell lung carcinoma.